The CoMO Scientific Advisory Group (CSAG) is a reference group of medical experts and clinicians.
The group advise CoMO’s Governing Council on meningitis issues and immunisation projects across CoMO’s three regions – Americas, Asia Pacific and Europe Africa.
After qualifying in medicine, James worked as a clinical doctor in the UK and rural South Africa before specialising in public health. An infectious disease epidemiologist, James has been involved in outbreak investigation and control at an international level, and has published many papers on risk factors for meningococcal disease and carriage.
Marco is the Head of Paediatrics and Associate Professor at Santa Casa de São Paulo School of Medical Sciences. An infectious diseases specialist, Marco is an active member of the Advisory Board on Immunization Practices in Brazil. His research is focused on the epidemiology and prevention of community-acquired infections.
May is a known Pediatric Infectious Disease Specialist in the Philippines. She is one of the founding members of the Pediatric Infectious Disease Society of the Philippines and Philippine Foundation for Vaccination. During her time, the Immunization Partners in Asia Pacific was organized. Currently, she is the Dean of the College of Medicine of Manila Theological College and the Head of Clinical Research Unit of Mary Chiles General Hospital and Far Eastern University-Nicanor Reyes Medical Foundation. She had several publications in the field of Clinical Research with more than 20 years of experience in vaccine clinical trials.
Catherine is Head of Paediatric Services at Hospital Louis Mourier, Professor of Paediatrics at the University of Paris VII and a medical doctor. An expert in the registration process for vaccines, antibiotics and anti-virals, Catherine is a contributor to the European Centre for Disease Prevention and Control and has previously worked on the Vaccine Working Party for Europe, the Middle East and Africa.
Priscilla is Senior Lecturer in epidemiology and public health at La Trobe University and has been involved in meningococcal disease research and public health prevention for more than 26 years.
Mark is Director of PATH’s pneumococcal, group B streptococcal and polyvalent meningococcal vaccine projects that seek to accelerate the development, licensure and availability of promising new vaccines for use in low-income settings. Mark is an immunologist with more than 30 years of experience in medical research, biotechnology, pharmaceuticals and vaccine development.